April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
Effect of Mesenchymal Stem Cells on Corneal Allograft Survival
Author Affiliations & Notes
  • Yiping Jin
    Schepens Eye Research, Boston, Massachusetts
  • Yinan Lan
    Schepens Eye Research, Boston, Massachusetts
  • Hyunsoo Lee
    Schepens Eye Research, Boston, Massachusetts
  • Sunil Chauhan
    Schepens Eye Research, Boston, Massachusetts
  • Footnotes
    Commercial Relationships  Yiping Jin, None; Yinan Lan, None; Hyunsoo Lee, None; Sunil Chauhan, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 1139. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yiping Jin, Yinan Lan, Hyunsoo Lee, Sunil Chauhan; Effect of Mesenchymal Stem Cells on Corneal Allograft Survival. Invest. Ophthalmol. Vis. Sci. 2011;52(14):1139.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Bone marrow-derived mesenchymal stem cells (MSC) have generated great interest for their ability to display a unique anti-inflammatory immunomodulatory property. MSC have immense potential for treating various diseases, especially those related to tissue damage involving immune reactions. The purpose of this study was to investigate whether MSC-mediated immunoregulation can prolong the corneal allograft survival.

Methods: : MSC were generated from the bone marrow of B6 mice. Phenotypically (expression of CD45-CD34-SCA1+CD29+) and functionally (differentiation into adipocytes) characterized MSC were used for both in vitro and in vivo assays. Immunoregulatory effect of MSC on CD3-mAb-mediated proliferation of both naïve and effector (allograft-primed) T cells were investigated in an in vitro co-culture assay using BrdU incorporation method. In addition, effect of MSC on expansion of CD4+Foxp3+ regulatory T cells (Tregs) was investigated using flow cytometry. To investigate effect of MSC on corneal allograft survival, BALB/c grafts were transplanted onto B6 recipients, and then after 24h, MSC (106) were intravenously injected to B6 recipients. Grafts were evaluated using slit-lamp microscopy at weekly intervals up to 8 weeks.

Results: : In MSC and T cell co-culture assay, there was significant suppression of CD3-Ab mediated proliferation of both naïve (22 ± 0.4%) and effector (24 ± 1.4%) T cells compared to the proliferation of CD3-Ab mediated T cells alone (P<0.05). In addition, the percentage of CD4+Foxp3+Treg population was increased when T cells were co-cultured with MSC (6.17%) compared to without MSC (3.12%). The corneal allograft rejection rate was significantly delayed in the recipients who received one dose of MSC injection post-operation compared to the allograft recipient without injection of MSC. The graft survival ratios in the MSC injection group were 50% (week2), 16.5% (week3) and 0% (week 4) respectively, while the graft survival ratios in non-MSC group were 14.3% (week2) and 0% (week3) respectively.

Conclusions: : Our data suggest that MSC have potential to prolong the corneal allograft survival. MSC-mediated suppression of naïve and effector T cell activation, and expansion of Tregs could be the possible mechanisms involved in the regulation of alloimmunity.

Keywords: cornea: basic science • immunomodulation/immunoregulation • transplantation 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.